• Users Online: 147
  • Print this page
  • Email this page

    Article Cited by others

ORIGINAL ARTICLE

The Use of ulipristal acetate (Esmya) prior to laparoscopic myomectomy: Help or hindrance?

Mallick Rebecca, Oxley Sam, Odejinmi Funlayo

Year : 2019| Volume: 8| Issue : 2 | Page no: 62-66

   This article has been cited by
 
1 What happens after randomised controlled trials? Uterine fibroids and ulipristal acetate: systematic review and meta-analysis of "real-world" data
Neha Shah,Elizabeth Egbase,Michael Sideris,Funlayo Odejinmi
Archives of Gynecology and Obstetrics. 2021;
[Pubmed]  [Google Scholar] [DOI]
2 Metastatic smooth muscle tumor of uncertain malignant potential after laparoscopic presuming myomectomy
Marisa Tossamartvorakul,MarieChristine Valerie R. Mendoza,Kuan-Gen Huang,Shu-Han Chang
Gynecology and Minimally Invasive Therapy. 2021; 10(3): 187
[Pubmed]  [Google Scholar] [DOI]
3 Hysteroscopic and ultrasonographic evaluation of ulipristal acetate treatment for symptomatic myomas in premenopausal women: a prospective study
Pasquale De Franciscis,Antonio Schiattarella,Gaetano Riemma,Domenico Labriola,Domenico Ambrosio,Salvatore Giovanni Vitale,Antonio Cianci,Gaspare Cucinella,Gloria Calagna,Nicola Colacurci
Minimally Invasive Therapy & Allied Technologies. 2020; : 1
[Pubmed]  [Google Scholar] [DOI]
4 Hormonal assessment of patients of reproductive age with uterine myoma for surgical treatment
A. V. Kozachenko,Z. V. Revazova,L. V. Adamyan,T. A. Demura,N. V. Zaytsev
Medical Council. 2019; (13): 29
[Pubmed]  [Google Scholar] [DOI]
5 Ulipristalacetat – aktueller Stellenwert in der Myombehandlung
Thomas Römer
Gynäkologische Endokrinologie. 2019;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article